The work of ERIC, the European Research Initiative on CLL
Which CLL patients would benefit from intensive therapy?
Potential concerns with ventoclax and Richter's transformation
Big data on efficacy and toxicity levels for ibrutinib in CLL
Are complex karyotypes reliable prognostic markers for CLL?